Tatsis Ourania sold VRTX
February 13, 2026 · Form 4 insider transaction
Tatsis Ourania sold 1,500 shares of Vertex Pharmaceuticals Incorporated at $499.99 per share, a transaction worth $750.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Footnotes
Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025.; Open market sales reported on this line occurred at a weighted average price of $499.99 (range $499.99 to $500.04).; Dr. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.